{"data":[{"accessionNo":"0001172661-26-003557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":"09075P204","securityClass":"Common Stock, par value $0.001","eventDate":"2026-06-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1621716,"percentOfClass":4.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001172661-26-003557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":"09075P204","securityClass":"Common Stock, par value $0.001","eventDate":"2026-06-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":1621716,"percentOfClass":4.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001172661-26-002135","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":"09075P204","securityClass":"Common Stock, par value $0.001","eventDate":"2026-03-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1910076,"percentOfClass":7.05,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001172661-26-002135","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":"09075P204","securityClass":"Common Stock, par value $0.001","eventDate":"2026-03-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":1910076,"percentOfClass":7.05,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001441449-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":"09075P105","securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-31","reportingPerson":"Qatar Investment Authority","reportingCik":null,"personType":"OO","sharesOwned":156066,"percentOfClass":0.6,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-26-012072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1833717,"percentOfClass":8.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-26-012072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1835192,"percentOfClass":8.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-26-012072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1835192,"percentOfClass":8.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-26-012072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1835192,"percentOfClass":8.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-25-095634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-29","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1026054,"percentOfClass":5.2,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-25-095634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-29","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1028053,"percentOfClass":5.2,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-25-095634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-29","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1028053,"percentOfClass":5.2,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/btai"},{"accessionNo":"0001104659-25-095634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001720893","issuerName":"BioXcel Therapeutics, Inc.","ticker":"BTAI","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-29","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1028053,"percentOfClass":5.2,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/btai"}],"updatedAt":"2026-11-04T08:04:52.366Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/btai","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}